Product Name

  • Name

    Tegafur

  • EINECS 241-846-2
  • CAS No. 17902-23-7
  • Article Data63
  • CAS DataBase
  • Density 1.45 g/cm3
  • Solubility
  • Melting Point 171-173 °C(lit.)
  • Formula C8H9FN2O3
  • Boiling Point
  • Molecular Weight 200.169
  • Flash Point
  • Transport Information UN 2811 6.1/PG 2
  • Appearance white crystalline powder
  • Safety 22-36/37/39-45
  • Risk Codes 23/24/25
  • Molecular Structure Molecular Structure of 17902-23-7 (Tegafur)
  • Hazard Symbols ToxicT
  • Synonyms 1-(2-Tetrahydrofuryl)-5-fluorouracil ; 1-(Tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione;1-(Tetrahydrofuran-2-yl)-5-fluorouracil;2,4(1H,3H)Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-;5-24-06-00285 (Beilstein Handbook Reference);5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione;
  • PSA 64.09000
  • LogP -0.01530

Synthetic route

tert-butyl 5-fluoro-2,6-dioxo-3-(tetrahydrofuran-2-yl)-3,6-dihydropyrimidine-1(2H)-carboxylate

tert-butyl 5-fluoro-2,6-dioxo-3-(tetrahydrofuran-2-yl)-3,6-dihydropyrimidine-1(2H)-carboxylate

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With isopropyl alcohol at 75℃; for 4h; Inert atmosphere;100%
5-fluorouracil
51-21-8

5-fluorouracil

Succinic semialdehyde
692-29-5

Succinic semialdehyde

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With indium(III) bromide; 1,1,3,3-Tetramethyldisiloxane In tetrahydrofuran at 15 - 20℃; for 12h; Solvent; Reagent/catalyst; Temperature;99.8%
2,3-dihydro-2H-furan
1191-99-7

2,3-dihydro-2H-furan

5-fluorouracil
51-21-8

5-fluorouracil

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With bis(acetylacetonate)nickel(II); tris(2,2′-bipyridine)ruthenium(II) bis(tetrafluoroborate) In tetrahydrofuran at 25 - 30℃; Temperature; Solvent; Wavelength; Reagent/catalyst; Irradiation;98.7%
With calcium chloride; trifluoroacetic acid In chloroform; N,N-dimethyl-formamide; toluene85.2%
With dimethylmonochlorosilane; triethylamine In acetonitrile at 16℃; Temperature;85%
5-fluorouracil
51-21-8

5-fluorouracil

tetrahydrofuran-2-yl benzoate
3333-44-6

tetrahydrofuran-2-yl benzoate

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With sodium acetate; tetra-(n-butyl)ammonium iodide In dichloromethane; water at 35℃; for 2h; Solvent; Temperature; Reagent/catalyst;95.2%
5-Fluoro-2,6-dioxo-3-(tetrahydro-furan-2-yl)-3,6-dihydro-2H-pyrimidine-1-carbothioic acid S-octyl ester
90162-98-4

5-Fluoro-2,6-dioxo-3-(tetrahydro-furan-2-yl)-3,6-dihydro-2H-pyrimidine-1-carbothioic acid S-octyl ester

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With isopropylamine In diethyl ether Ambient temperature;95%
tetrahydrofuran
109-99-9

tetrahydrofuran

5-fluorouracil
51-21-8

5-fluorouracil

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With dihydrogen peroxide; copper diacetate In N,N-dimethyl-formamide at 40℃; for 5h; Reagent/catalyst; Time; Solvent; Temperature;92.35%
With carbon tetrabromide; potassium carbonate In ethanol; water at 50 - 60℃; for 9.5h; Temperature; Reagent/catalyst; Inert atmosphere;82%
With 1-iodo-2,2,3,3,4,4,5,5,5-nonafluorobutane; caesium carbonate at 90℃; for 12h; Inert atmosphere; Sealed tube;39%
2,3-dihydro-2H-furan
1191-99-7

2,3-dihydro-2H-furan

5-fluorouracil
51-21-8

5-fluorouracil

dimethylsilicon dichloride
75-78-5

dimethylsilicon dichloride

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With sodium hydroxide; triethylamine In chloroform; acetonitrile85.5%
With pyridine In acetonitrile75.4%
5-fluoro-1-(2-tetrahydrofuryl)-6-hydroxy-5-methoxycarbonyl-5,6-dihydrouracil
65906-08-3

5-fluoro-1-(2-tetrahydrofuryl)-6-hydroxy-5-methoxycarbonyl-5,6-dihydrouracil

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With trifluoroacetic acid In water at 0℃; for 1104h;84%
(4,4-Dimethoxy-butoxy)-trimethyl-silane
70325-85-8

(4,4-Dimethoxy-butoxy)-trimethyl-silane

5-fluoro-2,4-bis(trimethylsilyloxy)pyrimidine
17242-85-2

5-fluoro-2,4-bis(trimethylsilyloxy)pyrimidine

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With tin(IV) chloride In 1,2-dichloro-ethane; acetonitrile addition at 0 deg C, stirring at 23-25 deg C, 1h;84%
2-chlorotetrahydrofuran
13369-70-5

2-chlorotetrahydrofuran

5-fluorouracil
51-21-8

5-fluorouracil

A

tegafur
17902-23-7

tegafur

B

1,3-bis(tetrahydro-2-furyl)-5-fluorouracil
62987-05-7

1,3-bis(tetrahydro-2-furyl)-5-fluorouracil

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl acetamide at 30℃; for 5h;A 75%
B 80%
piperidine
110-89-4

piperidine

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With pyridine79.3%
1,3-bis(tetrahydro-2-furyl)-5-fluorouracil
62987-05-7

1,3-bis(tetrahydro-2-furyl)-5-fluorouracil

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With water In ethanol at 50℃; for 2h;76%
2-acetoxytetrahydrofuran
1608-67-9

2-acetoxytetrahydrofuran

5-fluorouracil
51-21-8

5-fluorouracil

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
Stage #1: 2-acetoxytetrahydrofuran; 5-fluorouracil With 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide at 90℃; for 24h; Sealed tube;
Stage #2: With water In ethanol at 70℃; for 1.5h;
72%
In N,N-dimethyl-formamide at 140℃; for 2h;53%
With ammonium sulfate; cesium chloride; 1,1,1,3,3,3-hexamethyl-disilazane 2.) MeCN, 25 deg C, 3 h; Yield given. Multistep reaction;
2,3-dihydro-2H-furan
1191-99-7

2,3-dihydro-2H-furan

5-fluorouracil
51-21-8

5-fluorouracil

pyrographite
7440-44-0

pyrographite

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
In pyridine; chloroform; water72%
2,3-dihydro-2H-furan
1191-99-7

2,3-dihydro-2H-furan

5-fluorouracil
51-21-8

5-fluorouracil

A

tegafur
17902-23-7

tegafur

B

1,3-bis(tetrahydro-2-furyl)-5-fluorouracil
62987-05-7

1,3-bis(tetrahydro-2-furyl)-5-fluorouracil

Conditions
ConditionsYield
With pyridine; phosphorus pentaoxide In chloroformA 63%
B n/a
With 4-Methyl-1-benzolsulfonsaeure-trimethylsilylester In pyridine; 1,2-dichloro-ethane at 75 - 80℃; for 1h;A 41%
B n/a
With pyridine hydrochloride In 1,2-dichloro-ethane at 75 - 80℃; Product distribution; other temperature, other solvents, other reagents;A 1.73 g
B n/a
With pyridine In 1,2-dichloro-ethane at 75 - 80℃; Product distribution; other temperature, other solvents, other reagents;A 1.73 g
B n/a
2,3-dihydro-2H-furan
1191-99-7

2,3-dihydro-2H-furan

5-fluorouracil
51-21-8

5-fluorouracil

calcium bromide(CaBr2.2H2 O)

calcium bromide(CaBr2.2H2 O)

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
In chloroform; N,N-dimethyl-formamide; acetone62.5%
2,3-dihydro-2H-furan
1191-99-7

2,3-dihydro-2H-furan

5-fluorouracil
51-21-8

5-fluorouracil

Dimethylphenylsulfonium Perchlorate

Dimethylphenylsulfonium Perchlorate

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
In pyridine; chloroform; water58.3%
2,3-dihydro-2H-furan
1191-99-7

2,3-dihydro-2H-furan

5-fluoro-2,4-bis(trimethylsilyloxy)pyrimidine
17242-85-2

5-fluoro-2,4-bis(trimethylsilyloxy)pyrimidine

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With toluene-4-sulfonic acid In pyridine; 1,2-dichloro-ethane at 75 - 80℃; for 3h;51%
2-acetoxytetrahydrofuran
1608-67-9

2-acetoxytetrahydrofuran

5-fluorouracil
51-21-8

5-fluorouracil

A

tegafur
17902-23-7

tegafur

B

5-fluoro-3-(tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
63901-83-7

5-fluoro-3-(tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

C

1,3-bis(tetrahydro-2-furyl)-5-fluorouracil
62987-05-7

1,3-bis(tetrahydro-2-furyl)-5-fluorouracil

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide at 90℃; for 24h; Reagent/catalyst; Time; Sealed tube;A 51%
B 11%
C 29%
2,3-dihydro-2H-furan
1191-99-7

2,3-dihydro-2H-furan

5-fluoro-2,4-bis(trimethylsilyloxy)pyrimidine
17242-85-2

5-fluoro-2,4-bis(trimethylsilyloxy)pyrimidine

A

5-fluorouracil
51-21-8

5-fluorouracil

B

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With pyridine hydrochloride In chloroform at 60 - 70℃; Product distribution; other temperature, other solvents;A 0.6 g
B 44.5%
2-acetoxytetrahydrofuran
1608-67-9

2-acetoxytetrahydrofuran

5-fluorouracil
51-21-8

5-fluorouracil

A

tegafur
17902-23-7

tegafur

B

1,3-bis(tetrahydro-2-furyl)-5-fluorouracil
62987-05-7

1,3-bis(tetrahydro-2-furyl)-5-fluorouracil

Conditions
ConditionsYield
With ammonium sulfate; cesium chloride; 1,1,1,3,3,3-hexamethyl-disilazane 2.) MeCN, 25 deg C, 2 h; Yield given. Multistep reaction. Yields of byproduct given;
2-acetoxytetrahydrofuran
1608-67-9

2-acetoxytetrahydrofuran

1,3-dideuterio-5-fluorouracil

1,3-dideuterio-5-fluorouracil

A

tegafur
17902-23-7

tegafur

B

C8H8(2)HFN2O3
79994-85-7

C8H8(2)HFN2O3

C

C8H7(2)H2FN2O3
79994-86-8

C8H7(2)H2FN2O3

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 120℃; Mechanism; isotopic effect;
1-(2-tetrahydrofuryl)-5-methoxycarbonyluracil
65906-07-2

1-(2-tetrahydrofuryl)-5-methoxycarbonyluracil

A

5-fluorouracil
51-21-8

5-fluorouracil

B

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With sodium hydroxide; fluorine; acetic acid 1.) RT, 2.) H2O, 1 h, RT; Yield given. Multistep reaction;
1-(2-tetrahydrofuryl)-5-methoxycarbonyluracil
65906-07-2

1-(2-tetrahydrofuryl)-5-methoxycarbonyluracil

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 43 percent / F2/N2 (25percent) / H2O / Ambient temperature
2: 84 percent / CF3COOH / H2O / 1104 h / 0 °C
View Scheme
With hydrogenchloride; sodium hydroxide; ammonia; potassium carbonate; sodium sulfate In methanol; water; acetic acid
nicotinic acid
59-67-6

nicotinic acid

5-fluorouracil
51-21-8

5-fluorouracil

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
In N-methyl-acetamide; chloroform
5-fluorouracil
51-21-8

5-fluorouracil

2,3-tetrahydrofuran

2,3-tetrahydrofuran

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With tetramethlyammonium chloride In N-methyl-acetamide
ammonium hydroxide
1336-21-6

ammonium hydroxide

hypofluorous acid trifluoromethyl ester
373-91-1

hypofluorous acid trifluoromethyl ester

1-(tetrahydro-furan-2-yl)-uracil
18002-26-1

1-(tetrahydro-furan-2-yl)-uracil

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With nitrogen In methanol; dichloromethane
2-chlorotetrahydrofuran
13369-70-5

2-chlorotetrahydrofuran

bis-trimethylsilyl-5-fluoro-uracil
58138-78-6

bis-trimethylsilyl-5-fluoro-uracil

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
With ammonium hydroxide In tetrahydrofuran; methanol
2,3-dihydro-2H-furan
1191-99-7

2,3-dihydro-2H-furan

aqueous K2 CO3

aqueous K2 CO3

tegafur
17902-23-7

tegafur

Conditions
ConditionsYield
tin(IV) chloride In 1,4-dioxane; chloroform; isopropyl alcohol
morpholine
110-91-8

morpholine

formaldehyd
50-00-0

formaldehyd

tegafur
17902-23-7

tegafur

C13H18FN3O4
1062200-97-8

C13H18FN3O4

Conditions
ConditionsYield
In tetrahydrofuran; water at 20℃; for 18h;100%
benzyl bromide
100-39-0

benzyl bromide

tegafur
17902-23-7

tegafur

3-(phenylmethyl)-1-(2-tetrahydrofuryl)-5-fluorouracil
64504-15-0

3-(phenylmethyl)-1-(2-tetrahydrofuryl)-5-fluorouracil

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide; acetone at 50 - 60℃;95%
tegafur
17902-23-7

tegafur

trimethylsilylacetylene
1066-54-2

trimethylsilylacetylene

1-(tetrahydrofuran-2-yl)-3-(m-nitrobenzyl)-5-fluorouracil
98653-14-6

1-(tetrahydrofuran-2-yl)-3-(m-nitrobenzyl)-5-fluorouracil

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide for 1h; Ambient temperature;95%
chloro-methylsulfanyl-methane
2373-51-5

chloro-methylsulfanyl-methane

tegafur
17902-23-7

tegafur

3-methylthiomethyl-1-(tetrahydro-2-furyl)-5-fluorouracil
64504-18-3

3-methylthiomethyl-1-(tetrahydro-2-furyl)-5-fluorouracil

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide 1.) 1 h, below 10 deg C, 2.) room temp., 8 h;93.9%
tegafur
17902-23-7

tegafur

L-proline
147-85-3

L-proline

tegafur L-proline

tegafur L-proline

Conditions
ConditionsYield
In ethanol; acetone at 50℃; for 8h; Solvent; Temperature;93.23%
5-(4-bromomethyl-3-nitrophenyl)-10,15,20-triphenylporphyrin

5-(4-bromomethyl-3-nitrophenyl)-10,15,20-triphenylporphyrin

tegafur
17902-23-7

tegafur

5-(α-tegafur-m-nitro-p-tolyl)-10,15,20-triphenylporphyrin
1029885-24-2

5-(α-tegafur-m-nitro-p-tolyl)-10,15,20-triphenylporphyrin

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 70℃; for 10h;92.6%
tegafur
17902-23-7

tegafur

2-chloro-ethanol
107-07-3

2-chloro-ethanol

A

5-Fluoro-1,3-bis(2-hydroxyethyl)-uracil
55185-82-5

5-Fluoro-1,3-bis(2-hydroxyethyl)-uracil

B

N1-(2-furanidyl)-N3-(2-hydroxyethyl)-5-fluorouracil
82178-07-2

N1-(2-furanidyl)-N3-(2-hydroxyethyl)-5-fluorouracil

Conditions
ConditionsYield
With triethylamine In acetonitrile at 80℃; for 6h; Title compound not separated from byproducts;A n/a
B 91%
tegafur
17902-23-7

tegafur

1-(o-nitrobenzyl)-3-acetyl-5-fluorouracil
98653-12-4

1-(o-nitrobenzyl)-3-acetyl-5-fluorouracil

5-fluoro-3-(4-nitrobenzyl)-1-(tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
98653-15-7

5-fluoro-3-(4-nitrobenzyl)-1-(tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide for 1h; Ambient temperature;90%
tegafur
17902-23-7

tegafur

2-nitrophenylmethyl bromide
3958-60-9

2-nitrophenylmethyl bromide

1-(tetrahydrofuran-2-yl)-3-(o-nitrobenzyl)-5-fluorouracil
98653-13-5

1-(tetrahydrofuran-2-yl)-3-(o-nitrobenzyl)-5-fluorouracil

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide for 1h; Ambient temperature;90%
isonicotinamide
1453-82-3

isonicotinamide

tegafur
17902-23-7

tegafur

(RS)-5-fluoro-1-(tetrahydrofuran-2-yl) pyrimidine-2,4 (1H,3H)-dione*isonicotinamide

(RS)-5-fluoro-1-(tetrahydrofuran-2-yl) pyrimidine-2,4 (1H,3H)-dione*isonicotinamide

Conditions
ConditionsYield
In methanol at 60℃; for 120h;88.23%
p-methyloxycarbonylbenzyl chloride
34040-64-7

p-methyloxycarbonylbenzyl chloride

tegafur
17902-23-7

tegafur

methyl 4-((5-fluoro-2,6-dioxo-3-(tetrahydrofuran-2-yl)-2,3-dihydropyrimidin-1(6H)-yl)methyl)-benzoate

methyl 4-((5-fluoro-2,6-dioxo-3-(tetrahydrofuran-2-yl)-2,3-dihydropyrimidin-1(6H)-yl)methyl)-benzoate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;88%
With potassium carbonate In N,N-dimethyl-formamide at 20℃;
nicotinamide
98-92-0

nicotinamide

tegafur
17902-23-7

tegafur

(RS)-5-fluoro-1-(tetrahydrofuran-2-yl) pyrimidine-2,4 (1H,3H)-dione*nicotinamide

(RS)-5-fluoro-1-(tetrahydrofuran-2-yl) pyrimidine-2,4 (1H,3H)-dione*nicotinamide

Conditions
ConditionsYield
In methanol at 60℃; for 120h;87.93%
tegafur
17902-23-7

tegafur

2-hydroxyresorcinol
87-66-1

2-hydroxyresorcinol

(RS)-5-fluoro-1-(tetrahydrofuran-2-yl) pyrimidine-2,4 (1H,3H)-dione*pyrogallol

(RS)-5-fluoro-1-(tetrahydrofuran-2-yl) pyrimidine-2,4 (1H,3H)-dione*pyrogallol

Conditions
ConditionsYield
In methanol for 0.5h; Milling;87.43%

Tegafur Chemical Properties

IUPAC Name: 5-Fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione
Synonyms of  5-Fluoro-1-(tetrahydro-2-furyl)uracil (CAS NO.17902-23-7): 1-(2-Tetrahydrofuryl)-5-fluorouracil ; 1-(Tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione ; 1-(Tetrahydrofuran-2-yl)-5-fluorouracil ; 2,4(1H,3H)Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)- ; 5-24-06-00285 (Beilstein Handbook Reference) ; 5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione ; 5-Fluoro-1-(tetrahydro-2-furyl)uracil ; 5-Fluoro-1-(tetrahydro-3-furyl)uracil ; 5-Fluoro-1-(tetrahydrofuran-2-yl)uracil ; BRN 0525766 ; CCRIS 2762 ; Citofur ; Coparogin ; EINECS 241-846-2 ; Exonal ; FT-207 ; Furafluor ; Furflucil ; Lamar ; Lifril ; MJF-12264 ; N(sub 1)-(2'-Furanidyl)-5-fluouracil ; N(sub 1)-(2'-Furanidyl)-5-fluouracil [Czech] ; N(sub 1)-(2-Tetrahydrofuryl)-5-fluorouracil ; N1-(2-tetrahydrofuryl)-5-fluorouracil ; NSC-148958 ; Neberk ; Nitobanil ; Phthorafur ; Phthorafur [Czech] ; Racemic Ftorafur ; Riol ; Sinoflurol ; Sunfral ; Tefsiel C ; Tegafur ; Tegafurum ; Tegafurum [INN-Latin] ; UNII-1548R74NSZ ; Uracil, 1-(tetrahydrofuran-2-yl)-5-fluoro-  ; Uracil, 5-fluoro-1-(tetrahydro-2-furyl)-
CAS NO: 17902-23-7
Classification Code: Antimetabolites ; Antimetabolites, antineoplastic ; Antineoplastic ; Antineoplastic Agents ; Drug / Therapeutic Agent ; Human Data ; Mutation data ; Noxae ; Reproductive Effect ; Tumor data
Molecular Formula: C8H9FN2O3
Molecular Weight: 200.1671
Molecular Structure:

Melting Point: 171-173 °C 
H bond acceptors: 5
H bond donors: 1
Freely Rotating Bonds: 1
Polar Surface Area: 49.85 Å2
Index of Refraction: 1.557
Molar Refractivity: 44.28 cm3
Molar Volume: 137.4 cm3
Surface Tension: 51.1 dyne/cm
Density of  5-Fluoro-1-(tetrahydro-2-furyl)uracil (CAS NO.17902-23-7): 1.45 g/cm3

Tegafur Uses

 5-Fluoro-1-(tetrahydro-2-furyl)uracil (CAS NO.17902-23-7) can be used as an antineoplastic

Tegafur Production

  5-Fluoro-1-(tetrahydro-2-furyl)uracil (CAS NO.17902-23-7) can be derived from condensation 5 - fluorouracil and 2 - acetoxy-tetrahydrofuran with the yield of the Act only about 15%.
Another production method is based on  the synthesis of fluoride withthe starting material of 5 - fluorouracil, 6 methyl-2, and 3-methyl silicone alkyl ammonium chloride.

Tegafur Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD50 oral 36mg/kg (36mg/kg) BEHAVIORAL: TREMOR

GASTROINTESTINAL: NAUSEA OR VOMITING
Journal of Pharmaceutical Sciences. Vol. 73, Pg. 212, 1984.
dog LD50 oral 34mg/kg (34mg/kg) BEHAVIORAL: TREMOR

VASCULAR: OTHER CHANGES

GASTROINTESTINAL: NAUSEA OR VOMITING
Oyo Yakuri. Pharmacometrics. Vol. 20, Pg. 1009, 1980.
human LDLo intravenous 640mg/kg/8D (640mg/kg) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

GASTROINTESTINAL: NAUSEA OR VOMITING
Cancer Vol. 36, Pg. 103, 1975.
human TDLo intravenous 23mg/kg (23mg/kg) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" Cancer Vol. 36, Pg. 103, 1975.
man TDLo oral 197mg/kg/23D- (197mg/kg) BRAIN AND COVERINGS: ENCEPHALITIS

BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)

BEHAVIORAL: ANTIPSYCHOTIC
Internal Medicine. Vol. 31, Pg. 828, 1992.
mouse LD50 intraperitoneal 493mg/kg (493mg/kg)   National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986,
mouse LD50 intravenous 750mg/kg (750mg/kg)   United States Patent Document. Vol. #4130648,
mouse LD50 oral 775mg/kg (775mg/kg)   Yaoxue Tongbao. Bulletin of Pharmacology. Vol. 22, Pg. 27, 1987.
mouse LD50 subcutaneous 760mg/kg (760mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

GASTROINTESTINAL: NAUSEA OR VOMITING
Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 569, 1971.
rabbit LD50 oral 44mg/kg (44mg/kg) VASCULAR: OTHER CHANGES Oyo Yakuri. Pharmacometrics. Vol. 20, Pg. 1009, 1980.
rabbit LD50 unreported 40mg/kg (40mg/kg)   Eksperimental'naya i Klinicheskaya Farmakoterapiya. Vol. 7, Pg. 100, 1977.
rat LD50 intraperitoneal 700mg/kg (700mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 6, Pg. 2911, 1978.
rat LD50 intravenous 685mg/kg (685mg/kg)   Gan to Kagaku Ryoho. Cancer and Chemotherapy. Vol. 10, Pg. 1987, 1983.
rat LD50 oral 930mg/kg (930mg/kg) GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 6, Pg. 2911, 1978.
rat LD50 subcutaneous 600mg/kg (600mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 6, Pg. 2911, 1978.

Tegafur Consensus Reports

Reported in EPA TSCA Inventory.

Tegafur Safety Profile

Poison by ingestion. Moderately toxic to humans by intravenous route. Moderately toxic experimentally by intraperitoneal, intravenous, and subcutaneous routes. Experimental teratogenic data. Human systemic effects: nausea and vomiting. Experimental reproductive effects. Questionable human carcinogen producing gastrointestinal tumors. Human mutation data reported. Used as an anti-cancer agent. When heated to decomposition it emits very toxic fumes of F and NOx.
Safety Information of  5-Fluoro-1-(tetrahydro-2-furyl)uracil (CAS NO.17902-23-7).
Hazard Codes: ToxicT
Risk Statements: 23/24/25 
R23/24/25: Toxic by inhalation, in contact with skin and if swallowed.
Safety Statements: 22-36/37/39-45 
S22: Do not breathe dust. 
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection. 
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
RIDADR: UN 2811 6.1/PG 2
WGK Germany: 3
RTECS: YR0450000

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View